Inhibition of human thymidine phosphorylase by conformationally constrained pyrimidine nucleoside phosphonic acids and their "open-structure" isosteres

Eur J Med Chem. 2014 Mar 3:74:145-68. doi: 10.1016/j.ejmech.2013.12.026. Epub 2014 Jan 3.

Abstract

A series of conformationally constrained uridine-based nucleoside phosphonic acids containing annealed 1,3-dioxolane and 1,4-dioxane rings and their "open-structure" isosteres were synthesized and evaluated as potential multisubstrate-like inhibitors of the human recombinant thymidine phosphorylase (TP, EC 2.4.2.4) and TP obtained from peripheral blood mononuclear cells (PBMC). From a large set of tested nucleoside phosphonic acids, several potent compounds were identified that exhibited Ki values in the range of 0.048-1 μM. The inhibition potency of the studied compounds strongly depended on the degree of conformational flexibility of the phosphonate moiety, the stereochemical arrangement of the sugar-phosphonate component, and the substituent at position 5 of the pyrimidine nucleobase.

Keywords: Bi-substrate-like inhibitor; Conformationally constrained nucleotide analog; Human thymidine phosphorylase; Michael addition; PBMC; Phosphonate.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Enzyme Inhibitors / pharmacology*
  • Humans
  • Molecular Conformation
  • Phosphorous Acids / chemistry
  • Phosphorous Acids / pharmacology*
  • Pyrimidine Nucleosides / pharmacology*
  • Structure-Activity Relationship
  • Thymidine Phosphorylase / antagonists & inhibitors*

Substances

  • Enzyme Inhibitors
  • Phosphorous Acids
  • Pyrimidine Nucleosides
  • Thymidine Phosphorylase